
LGM Pharma
LGM Pharma, an innovation-driven company involved in distribution of cGMP active pharmaceutical ingredients.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
* | N/A | Growth Equity VC | |
Total Funding | 000k |
Related Content
LGM Pharma specializes in sourcing and delivering active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company serves a diverse range of clients, including pharmaceutical manufacturers and research organizations, by providing high-quality APIs and comprehensive CDMO (Contract Development and Manufacturing Organization) services. Operating in the highly regulated pharmaceutical market, LGM Pharma leverages its strong relationships with world-class manufacturers to minimize supply chain risks and ensure timely delivery of essential ingredients. The business model revolves around securing, importing, and delivering niche and complex APIs, thereby enabling clients to bring their pharmaceutical products to market more efficiently. Revenue is generated through the sale of APIs and the provision of development and manufacturing services. LGM Pharma's expertise spans from early-stage research and development (R&D) to FDA-approved cGMP (current Good Manufacturing Practice) manufacturing, ensuring that clients achieve sustainable success in the pharmaceutical market.
Keywords: API sourcing, pharmaceutical ingredients, CDMO services, supply chain management, FDA-approved, cGMP manufacturing, niche APIs, pharmaceutical R&D, market entry, pharmaceutical manufacturing.